Astrana Health Inc (ASTH)
38.50
-0.39
(-1.00%)
USD |
NASDAQ |
May 13, 12:27
Astrana Health Enterprise Value: 1.618B for May 10, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 10, 2024 | 1.618B |
| May 09, 2024 | 1.625B |
| May 08, 2024 | 1.582B |
| May 07, 2024 | 1.574B |
| May 06, 2024 | 1.592B |
| May 03, 2024 | 1.553B |
| May 02, 2024 | 1.535B |
| May 01, 2024 | 1.544B |
| April 30, 2024 | 1.539B |
| April 29, 2024 | 1.574B |
| April 26, 2024 | 1.519B |
| April 25, 2024 | 1.512B |
| April 24, 2024 | 1.533B |
| April 23, 2024 | 1.554B |
| April 22, 2024 | 1.627B |
| April 19, 2024 | 1.617B |
| April 18, 2024 | 1.611B |
| April 17, 2024 | 1.626B |
| April 16, 2024 | 1.649B |
| April 15, 2024 | 1.709B |
| April 12, 2024 | 1.783B |
| April 11, 2024 | 1.807B |
| April 10, 2024 | 1.804B |
| April 09, 2024 | 1.871B |
| April 08, 2024 | 1.854B |
| Date | Value |
|---|---|
| April 05, 2024 | 1.832B |
| April 04, 2024 | 1.815B |
| April 03, 2024 | 1.849B |
| April 02, 2024 | 1.847B |
| April 01, 2024 | 1.846B |
| March 31, 2024 | 1.844B |
| March 28, 2024 | 1.661B |
| March 27, 2024 | 1.622B |
| March 26, 2024 | 1.550B |
| March 25, 2024 | 1.540B |
| March 22, 2024 | 1.557B |
| March 21, 2024 | 1.614B |
| March 20, 2024 | 1.642B |
| March 19, 2024 | 1.571B |
| March 18, 2024 | 1.553B |
| March 15, 2024 | 1.567B |
| March 14, 2024 | 1.576B |
| March 13, 2024 | 1.617B |
| March 12, 2024 | 1.664B |
| March 11, 2024 | 1.671B |
| March 08, 2024 | 1.784B |
| March 07, 2024 | 1.783B |
| March 06, 2024 | 1.744B |
| March 05, 2024 | 1.717B |
| March 04, 2024 | 1.750B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
529.00M
Minimum
Mar 16 2020
5.276B
Maximum
Nov 16 2021
1.567B
Average
1.470B
Median
Enterprise Value Benchmarks
| American Shared Hospital Services | 28.79M |
| Novo Integrated Sciences Inc | 13.40M |
| Cryo-Cell International Inc | 81.68M |
| P3 Health Partners Inc | 443.71M |
| Biote Corp | 208.79M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 14.84M |
| Revenue (Quarterly) | 404.36M |
| Total Expenses (Quarterly) | 374.22M |
| EPS Diluted (Quarterly) | 0.31 |
| Gross Profit Margin (Quarterly) | 18.29% |
| Profit Margin (Quarterly) | 3.67% |
| Earnings Yield | 3.43% |
| Operating Earnings Yield | 5.09% |
| Normalized Earnings Yield | 3.306 |